Skip to main content
NIH funding notice RFA-DE-23-013

AHEAD (Advancing Head and Neck Cancer Early Detection Research) (U01 Clinical Trial Not Allowed)

Closed on March 14, 2023.

Posted
October 13, 2022
Close date
March 14, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
7
7 new
Median first-year cost
$706,647
$4,329,223 in all
Institutions
7
7 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. COLUMBIA UNIVERSITY HEALTH SCIENCES1
  2. GEORGETOWN UNIVERSITY1
  3. H. LEE MOFFITT CANCER CTR & RES INST1
  4. MASSACHUSETTS GENERAL HOSPITAL1
  5. UNIVERSITY OF CALIFORNIA, SAN DIEGO1

and 2 other institutions

Most frequent study sections

  1. Special Emphasis Panel (ZDE1 AC (02))6
  2. ZDE1-AC(01)1
7 awards under RFA-DE-23-013 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2023Mapping immuno-genomic drivers of the head and neck precancer invasive-disease transition1U01CA290479-01Alexandrov, Ludmil BGutkind, Jorge SilvioLippman, Scott MUNIVERSITY OF CALIFORNIA, SAN DIEGO, CAFirst-year cost $790,000Study section ZDE1
FY2023Immune and transcriptomic biomarkers of progressive oral premalignant lesions1U01DE033351-01Momen Heravi, FatemehCOLUMBIA UNIVERSITY HEALTH SCIENCES, NYFirst-year cost $743,064Study section ZDE1
FY2023Biomarker Approach to Screening for the early detection of HPV-related Oropharyngeal Cancer (BASH OPC)1U01DE033329-01Amelio, Antonio LuigiGiuliano, Anna R.H. LEE MOFFITT CANCER CTR & RES INST, FLFirst-year cost $727,078Study section ZDE1
FY2023Oral Dysplasias to Carcinomas: Multi-omics Study of Progression1U01DE033348-01Rozek, LauraGEORGETOWN UNIVERSITY, DCFirst-year cost $706,647Study section ZDE1
FY2023Advancing On-Slide and Optical Biopsy Tools to Detect High-Risk Oral Premalignancy1U01DE033330-01Chinn, Steven BennettLei, Yu LeoWang, Thomas DUNIVERSITY OF MICHIGAN AT ANN ARBOR, MIFirst-year cost $689,330Study section ZDE1
FY2023Combined Imaging and RNA Analyses to Predict Head and Neck Cancer Recurrence1R56DE033344-01Li, HuaWang, XiaoweiWASHINGTON UNIVERSITY, MOFirst-year cost $673,102Study section ZDE1
FY2023Early detection and risk of head and neck cancer through immune based spatial omics1U01DE033324-01Pai, Sara IsabelWeissleder, Md, Phd, RalphMASSACHUSETTS GENERAL HOSPITAL, MAFirst-year cost $2Study section ZDE1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-DE-23-013: AHEAD (Advancing Head and Neck Cancer Early Detection Research) (U01 Clinical Trial Not Allowed) | ScienceDex | ConductScience